From: Allograft tolerance after adult living donor liver transplantation: a case-control study
 | Unadjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value |
---|---|---|---|---|
Age at LT | 1.04 (1.01–1.08) | 0.01* | 1.034 (0.99–1.08) | 0.082 |
Male | 1.283 (0.54–3.06) | 0.575 | 1.7 (0.61–4.76) | 0.308 |
Pre-LT MELD | 0.95 (0.91–0.997) | 0.037* | 0.95 (0.9–0.99) | 0.033* |
Related donation | 1.53 (0.89–2.61) | 0.118 | 1.23 (0.68–2.24) | 0.492 |
ABO-Rh compatibility | 0.87 (0.53–1.44) | 0.597 | 0.81 (0.46–1.46) | 0.459 |
Diagnosis HCV/HCC | 0.94 (0.57–1.55) | 0.804 | 0.62 (0.35–1.09) | 0.096 |
Diagnosis HCV/Others | 0.39 (0.15–1.4) | 0.06 | 0.23 (0.08–0.72) | 0.011* |
ACR | 0.34 (0.21–0.55) | < 0.001* | 0.36 (0.21–0.62) | 0.001* |
Post-LT viral hepatitis | 0.44 (0.27–0.73) | 0.001* | 0.44 (0.25–0.78) | 0.005* |
Biliary complications | 0.31 (0.19–0.5) | < 0.001* | 0.28 (0.16–0.48) | 0.001* |